How do I buy Pfizer (PFE) stock?

Buying Pfizer (PFE) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "PFE", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy PFE by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if PFE is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Pfizer (PFE) Stock

Q: What is the minimum investment for PFE on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Pfizer from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · PFE

Trade PFE

Key stats

Market cap: $170.99B
Price / Earnings ratio: 42.4x
EPS (TTM): $0.71
Volume: Loading
52-week high: $31.06
52-week low: $23.62
Dividend yield: 5.59%
Dividend amount (latest): $0.43
EPS vs analyst estimate: +33.8%Q3 FY25 · $0.87 vs $0.65

Source: third-party data provider, as of November 5, 2026

EPS estimate: analyst consensus

Compare with PFE

Technical indicators

RSI 14: 64.46
MACD 12/26/9: 0.58
EMA 9 of MACD: 0.54
MACD histogram: 0.05
SMA 50: $28.68; Price above SMA 50
EMA 50: $28.72; Price above EMA 50
SMA 200: $26.87; Price above SMA 200
EMA 200: $27.12; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 8 analyst ratings

Strong Sell0

Sell0

Hold6

Buy2

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

120B79B40B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

272B179B90B0

Revenue to Profit

2025

$62.6B

Revenue

$0.0

Cost of revenue

$46.5B

Gross profit

$0.0

Operating expenses

$7.8B

Net income

Earnings

EPS forecast

Actual EPS

$0.87

$0.65

Q3FY25

$0.61

Q4FY25

$0.74

Q1FY26

$0.70

Q2FY26

$0.92

Q3FY26

The market is expecting earnings per share of $0.92 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Pfizer

At Pfizer, we apply science and our global resources to bring therapies and healthcare products to people that extend and significantly improve their lives. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.

SectorHealthcare

IndustryDrug Manufacturers - General

Employees75,000

CEODr. Albert Bourla D.V.M., Ph.D.

IPO DateJun 22, 1942

HeadquartersNew York, NY

Key Executives

Name	Title	Year Born
Dr. Albert Bourla D.V.M., Ph.D.	Chairman of the Board & CEO	1962
Ms. Cecile Guegan	Interim CFO & Executive VP	1971
Dr. Chris Boshoff FMedSci, M.D., Ph.D.	Chief Scientific Officer and President of Research & Development	1964
Mr. Douglas M. Lankler	Executive VP & Chief Legal Officer	1966
Mr. Aamir Malik	Executive VP & Chief U.S. Commercial Officer	1976
Ms. Jennifer B. Damico	Senior VP, Controller & Principal Accounting Officer	1969
Mr. Dennis P. Hancock	Executive VP & Chief Information Officer	—
Ms. Francesca M. DeMartino	Chief Investor Relations Officer	—
Ms. Payal Sahni Becher	Chief People Experience Officer & Executive VP	1975
Dr. Michael S. Vincent M.D., Ph.D.	Senior VP and Chief Scientific Officer of Inflammation & Immunology	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											+11.2	+8.0
2022	-7.0	-11.6	+13.2	-4.8	+9.7	+0.1	-3.4	-10.6	-6.2	+5.5	+4.4	+0.3
2023	-13.9	-7.7	+1.5	-5.9	-3.0	-3.5	-1.6	-0.6	-7.3	-10.0	-0.1	-0.4
2024	-8.9	-2.7	+4.4	-7.6	+5.4	-4.5	+8.2	-5.4	+2.3	-1.3	-6.7	+2.7
2025	-0.3	+0.9	-3.5	-0.5	-1.8	+3.3	-7.0	+5.4	+2.0	-9.4	+4.4	-1.5
2026	+5.0	+3.7	+3.0	-6.5	-0.6	-6.0	+4.7	+13.7	-0.1	+8.5	+0.4

Stocks in the same sector

FAQ

Buying Pfizer (PFE) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "PFE", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy PFE by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Pfizer from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, Pfizer regularly pays dividends to shareholders. Currently, the estimated dividend yield for PFE is around 5.59% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Pfizer (PFE) Stock

Key stats

Compare with PFE

Recent news

Pfizer Q3 Earnings Call Highlights

Pfizer Q3 Earnings Call Highlights

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market

Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market

Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Despite New Phase 3 Trial

Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Despite New Phase 3 Trial

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Pfizer Q3 Earnings Call Highlights

Pfizer Q3 Earnings Call Highlights

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market

Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market

Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Despite New Phase 3 Trial

Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Despite New Phase 3 Trial

UPS's $5.4 Billion Dividend Bill Exceeded Its Free Cash Flow. Is the Payout at Risk?

UPS's $5.4 Billion Dividend Bill Exceeded Its Free Cash Flow. Is the Payout at Risk?

Q3 Earnings & JOLTS Report on Midterm Voting Day

Q3 Earnings & JOLTS Report on Midterm Voting Day

Pfizer (PFE) Reports Q3 Earnings: What Key Metrics Have to Say

Pfizer (PFE) Reports Q3 Earnings: What Key Metrics Have to Say

PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance

PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance

Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction

Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction

Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates

Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates

About Pfizer

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade